Citius Oncology, Inc. (CTOR) Financials

CTOR Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 100.7 million 65.4 million
Dec. 31, 2025 110.0 million 51.6 million
Sept. 30, 2025 100.9 million 56.1 million
June 30, 2025 91.7 million 59.3 million

CTOR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -4.0 million 3.5 million
Dec. 31, 2025 -7.4 million 4.0 million
Sept. 30, 2025 -5.5 million 2.3 million
June 30, 2025 ? 2125

CTOR Net Income

No data available :(

CTOR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 2.6 million 3.8 million -
Dec. 31, 2025 7.3 million 3.8 million -
Sept. 30, 2025 3.9 million 3.8 million -
June 30, 2025 112 3.8 million -

CTOR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 100.0 million
Dec. 31, 2025 87.5 million
Sept. 30, 2025 80.9 million
June 30, 2025 71.6 million

CTOR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 5 2.8 million 27.2 million -
Dec. 31, 2025 4 1.0 million 6.8 million -
Sept. 30, 2025 5 1.1 million 3.6 million -
June 30, 2025 - 938277 4.0 million -

CTOR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 1.7 million 328878
Dec. 31, 2025 3.9 million 789208
Sept. 30, 2025 - -
June 30, 2025 - -

CTOR

Price: $0.78

52 week price:
0.49
6.19

Earnings Per Share: -0.48 USD

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 72.5 million

Links: